quant Healthcare Fund - Growth Option - Regular Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 17.3999 ↓ -0.91%
[as on 14 October, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of quant Healthcare Fund - Growth Option - Regular Plan and its peers as on 14 October, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
quant Healthcare Fund - Growth Option - Regular Plan 16.3% -0.91% -1.65% -4.67% 0.64% 12.7% 17.47%---
SBI MNC FUND - REGULAR PLAN -GROWTH 11.2% -0.11% -1.45% -4.41% 0.01% 11.81% 5.26% 6.32% 12.36% 10.16%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 16.01% -0.8% -2.95% -6.63% -2.66% 13.09% 20.5% 15.81% 23.96% 13.09%
SBI COMMA Fund - REGULAR PLAN - Growth 0.51% 1.04% -0.8% -5.2% -3.4% 5.99% 13.12% 7.79% 17.48% 13.47%
SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth -8.82% -0.34% -0.36% -3.55% -5.02% -6.18% 6.71% 5.56% 11.27% 10.45%
SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH -3.13% 0.7% -0.87% -3.41% -6.19% -0.53% 10.47% 13.29% 18.01% 13.94%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 30.19% -6.4%

Discrete returns (monthly)

MonthDec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026
Returns -1.91% -5.2% 2.44% -5.47% 6.1% 4.92% 6.43% 2.69% 5.79% -2.96%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 1.59%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
70.33% 5.57% (Arbitrage: 0.00%) 0.00% 0.00% -4.55%

Equity

NameSymbol / ISINSectorWeight %Other links
Glaxosmithkline Pharmaceuticals LtdGLAXO (INE159A01016)Pharmaceuticals & Biotechnology10.58%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology9.30%
Pfizer LtdPFIZER (INE182A01018)Pharmaceuticals & Biotechnology8.83%
Alivus Life SciencesALIVUS (INE03Q201024)Pharmaceuticals & Biotechnology8.08%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology7.03%
SMS Pharmaceuticals LimitedSMSPHARMA (INE812G01025)Pharmaceuticals & Biotechnology6.71%
IPCA Laboratories LtdIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology6.22%
Zydus Wellness LtdZYDUSWELL (INE768C01028)Food Products5.64%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology5.18%
Strides Pharma Science LtdSTAR (INE939A01011)Pharmaceuticals & Biotechnology2.45%
Sumitomo Chemical India LimitedSUMICHEM (INE258G01013)Fertilizers & Agrochemicals0.31%

Debt

NameIsinRatingWeight %Yield
91 Days Treasury Bill 03-Sep-2026IN002026X099N.A.0.70%5.20%
91 Days Treasury Bill 10-Sep-2026IN002026X107N.A.0.70%5.18%
91 Days Treasury Bill 17-Sep-2026IN002026X115N.A.0.70%5.00%
91 Days Treasury Bill 15-Oct-2026IN002026X156N.A.0.70%5.11%
91 Days Treasury Bill 22-Oct-2026IN002026X164N.A.0.70%5.10%
91 Days Treasury Bill 05-Nov-2026IN002026X180N.A.0.69%5.25%
91 Days Treasury Bill 19-Nov-2026IN002026X206N.A.0.69%5.26%
91 Days Treasury Bill 27-Nov-2026IN002026X214N.A.0.69%5.27%
Portfolio data is as on date 31 August, 2026

NAV history

quant Healthcare Fund - Growth Option - Regular Plan - 30 days NAV (Net asset value) history

DateNAV% change
14 October, 202617.3999 -0.91%
13 October, 202617.5598 0.37%
12 October, 202617.4954 0.34%
9 October, 202617.4363 0.91%
8 October, 202617.2791 -2.34%
7 October, 202617.6925 -0.82%
6 October, 202617.8394 1.11%
5 October, 202617.6436 -0.53%
1 October, 202617.7372 -0.9%
30 September, 202617.8982 -1.61%
29 September, 202618.192 -0.14%
28 September, 202618.2166 -0.6%
25 September, 202618.3263 -0.39%
24 September, 202618.3974 -0.58%
23 September, 202618.505 0.83%
22 September, 202618.3532 -0.62%
21 September, 202618.468 0.53%
18 September, 202618.3701 0.8%
17 September, 202618.2236 0.77%
16 September, 202618.0839 0.65%
15 September, 202617.9674 -1.56%
11 September, 202618.2529 -0.25%
10 September, 202618.2983 -0.35%
9 September, 202618.3632 -0.69%
8 September, 202618.4904 0%
7 September, 202618.4909 1.45%
4 September, 202618.2274 -0.41%
3 September, 202618.3029 -0.24%
2 September, 202618.3475 -0.52%
1 September, 202618.4439

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of quant Healthcare Fund - Growth Option - Regular Plan?
    The latest NAV of quant Healthcare Fund - Growth Option - Regular Plan is 17.3999 as on 14 October, 2026.
  • What are YTD (year to date) returns of quant Healthcare Fund - Growth Option - Regular Plan?
    The YTD (year to date) returns of quant Healthcare Fund - Growth Option - Regular Plan are 16.3% as on 14 October, 2026.
  • What are 1 year returns of quant Healthcare Fund - Growth Option - Regular Plan?
    The 1 year returns of quant Healthcare Fund - Growth Option - Regular Plan are 12.7% as on 14 October, 2026.
  • What are 3 year CAGR returns of quant Healthcare Fund - Growth Option - Regular Plan?
    The 3 year annualized returns (CAGR) of quant Healthcare Fund - Growth Option - Regular Plan are 17.47% as on 14 October, 2026.
  • What are top 10 holdings of quant Healthcare Fund - Growth Option - Regular Plan?
    Top 10 holdings of quant Healthcare Fund - Growth Option - Regular Plan are:
    • Glaxosmithkline Pharmaceuticals Ltd
    • Zydus Lifesciences Limited
    • Pfizer Ltd
    • Alivus Life Sciences
    • Concord Biotech Limited
    • SMS Pharmaceuticals Limited
    • IPCA Laboratories Ltd
    • Zydus Wellness Ltd
    • Aurobindo Pharma Limited
    • Strides Pharma Science Ltd
    • Sumitomo Chemical India Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for quant Healthcare Fund - Growth Option - Regular Plan?
    quant Healthcare Fund - Growth Option - Regular Plan is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.